409 related articles for article (PubMed ID: 24037963)
1. Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
Kleiner DE; Chalasani NP; Lee WM; Fontana RJ; Bonkovsky HL; Watkins PB; Hayashi PH; Davern TJ; Navarro V; Reddy R; Talwalkar JA; Stolz A; Gu J; Barnhart H; Hoofnagle JH;
Hepatology; 2014 Feb; 59(2):661-70. PubMed ID: 24037963
[TBL] [Abstract][Full Text] [Related]
2. Comparative histologic features among liver biopsies with biliary-pattern injury and confirmed clinical diagnoses.
Yu S; Vidal B; Peric M; Rosenbaum MW; Cates JMM; Gonzalez RS
Hum Pathol; 2024 Apr; 146():8-14. PubMed ID: 38479481
[TBL] [Abstract][Full Text] [Related]
3. Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury.
Suzuki A; Barnhart H; Gu J; Bonkovsky HL; Tillmann HL; Fontana RJ; Kleiner DE;
Liver Int; 2017 Nov; 37(11):1723-1730. PubMed ID: 28161910
[TBL] [Abstract][Full Text] [Related]
4. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.
Suzuki A; Brunt EM; Kleiner DE; Miquel R; Smyrk TC; Andrade RJ; Lucena MI; Castiella A; Lindor K; Björnsson E
Hepatology; 2011 Sep; 54(3):931-9. PubMed ID: 21674554
[TBL] [Abstract][Full Text] [Related]
5. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and pathological features in 138 cases of drug-induced liver injury].
Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
[TBL] [Abstract][Full Text] [Related]
7. Liver Histology: Diagnostic and Prognostic Features.
Gasmi B; Kleiner DE
Clin Liver Dis; 2020 Feb; 24(1):61-74. PubMed ID: 31753251
[TBL] [Abstract][Full Text] [Related]
8. A proposed pathologic sub-classification of drug-induced liver injury.
Wang T; Zhao X; Shao C; Ye L; Guo J; Peng N; Zhang H; Li J; Kong Y; You H; Jia J
Hepatol Int; 2019 May; 13(3):339-351. PubMed ID: 30977034
[TBL] [Abstract][Full Text] [Related]
9. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.
Fontana RJ; Hayashi PH; Barnhart H; Kleiner DE; Reddy KR; Chalasani N; Lee WM; Stolz A; Phillips T; Serrano J; Watkins PB;
Am J Gastroenterol; 2015 Oct; 110(10):1450-9. PubMed ID: 26346867
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and pathological analysis of 100 cases of drug-induced liver injury].
Zhou GD; Zhao JM; Zhang LX; Sun YL; Pan D; Yang JF; Zhao YL
Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):212-5. PubMed ID: 17407714
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study.
Molleston JP; Fontana RJ; Lopez MJ; Kleiner DE; Gu J; Chalasani N;
J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):182-9. PubMed ID: 21788760
[TBL] [Abstract][Full Text] [Related]
12. Role of liver biopsy in the era of clinical prediction scores for "drug-induced liver injury" (DILI): experience of a tertiary referral hospital.
Costa-Moreira P; Gaspar R; Pereira P; Lopes S; Canão P; Lopes J; Carneiro F; Macedo G
Virchows Arch; 2020 Oct; 477(4):517-525. PubMed ID: 32377873
[TBL] [Abstract][Full Text] [Related]
13. The pathology of drug-induced liver injury.
Kleiner DE
Semin Liver Dis; 2009 Nov; 29(4):364-72. PubMed ID: 19826970
[TBL] [Abstract][Full Text] [Related]
14. Presentations, Causes and Outcomes of Drug-Induced Liver Injury in Egypt.
Alhaddad O; Elsabaawy M; Abdelsameea E; Abdallah A; Shabaan A; Ehsan N; Elrefaey A; Elsabaawy D; Salama M
Sci Rep; 2020 Mar; 10(1):5124. PubMed ID: 32198411
[TBL] [Abstract][Full Text] [Related]
15. Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease.
Palmer M; Regev A; Lindor K; Avigan MI; Dimick-Santos L; Treem W; Marcinak JF; Lewis JH; Anania FA; Seekins D; Shneider BL; Chalasani N
Aliment Pharmacol Ther; 2020 Jan; 51(1):90-109. PubMed ID: 31762074
[TBL] [Abstract][Full Text] [Related]
16. An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.
Hisamochi A; Kage M; Ide T; Arinaga-Hino T; Amano K; Kuwahara R; Ogata K; Miyajima I; Kumashiro R; Sata M; Torimura T
J Gastroenterol; 2016 Jun; 51(6):597-607. PubMed ID: 26519284
[TBL] [Abstract][Full Text] [Related]
17. Histopathological characteristics of liver biopsy performed at different time points in drug-induced liver injury.
Wang Y; Ma Z; Guo T; Liu J; Li M; Zhao X
Histol Histopathol; 2024 Jan; 39(1):79-90. PubMed ID: 37017203
[TBL] [Abstract][Full Text] [Related]
18. Histological patterns in drug-induced liver disease.
Ramachandran R; Kakar S
J Clin Pathol; 2009 Jun; 62(6):481-92. PubMed ID: 19474352
[TBL] [Abstract][Full Text] [Related]
19. Tetracycline-induced bile duct paucity and prolonged cholestasis.
Hunt CM; Washington K
Gastroenterology; 1994 Dec; 107(6):1844-7. PubMed ID: 7958700
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of histologic changes in the livers of patients with early and late hepatic artery thrombosis.
Lee M; Agostini-Vulaj D; Gonzalez RS
Hum Pathol; 2019 Aug; 90():8-13. PubMed ID: 31075300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
